1. CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells
   Alessandra Gentilini et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
2. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway
   Susu Zheng et al, 2017, Future Oncology CrossRef
3. New insights on the role of vascular endothelial growth factor in biliary pathophysiology
   Valeria Mariotti et al, 2021, JHEP Reports CrossRef
4. The Investigative Therapeutic Pipeline for Cholangiocarcinoma: Insights from Model Systems
   Luca Maroni et al, 2021, Diagnosis and Management of Cholangiocarcinoma CrossRef
5. The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models
   Pimpawadee Phukhum et al, 2023, Scientific Reports CrossRef
6. Vascular endothelial growth factor‐C in activating vascular endothelial growth factor receptor‐3 and chemokine receptor‐4 in melanoma adhesion
   Yvette N. Hlophe et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
7. The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
   Chunping Cai et al, 2022, World Journal of Surgical Oncology CrossRef
8. Preoperative Computed Tomography Features of Intrahepatic Cholangiocarcinoma for Predicting Lymph Node Metastasis and Overall Survival
   Yong Zhu et al, 2019, Journal of Computer Assisted Tomography CrossRef